Identification and characterization of novel salivary thrombin inhibitors from the ixodidae tick, Haemaphysalis longicornis.

Novel antithrombin molecules were identified from the ixodidae tick, Haemaphysalis longicornis. These molecules, named madanin 1 and 2, are 7-kDa proteins and show no significant similarities to any previously identified proteins. Assays using human plasma showed that madanin 1 and 2 dose-dependently prolonged both activated partial thromboplastin time and prothrombin time, indicating that they inhibit both the intrinsic and extrinsic pathways. Direct binding assay by surface plasmon resonance measurement demonstrated that madanin 1 and 2 specifically interacted with thrombin. Furthermore, it was clearly shown that madanin 1 and 2 inhibited conversion of fibrinogen into fibrin by thrombin, thrombin-catalyzed activation of factor V and factor VIII, and thrombin-induced aggregation of platelets without affecting thrombin amidolytic activity. These results suggest that madanin 1 and 2 bind to the anion-binding exosite 1 on the thrombin molecule, but not to the active cleft, and interfere with the association of fibrinogen, factor V, factor VIII and thrombin receptor on platelets with an anion-binding exosite 1. They appear to be exosite 1-directed competitive inhibitors.

[1]  K. Broady,et al.  Anticoagulant in the tick Ixodes holocyclus. , 1991, Australian veterinary journal.

[2]  R. Marchi,et al.  Invertebrate compounds acting on the hemostatic mechanism. , 1999, Blood Coagulation and Fibrinolysis.

[3]  J. Fareed,et al.  Thrombin Anion‐binding Exosite Interactions with Heparin and Various Polyanions a , 1989, Annals of the New York Academy of Sciences.

[4]  G. Hortin,et al.  Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates. , 1991, The Journal of biological chemistry.

[5]  M. Zabinski,et al.  Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition. , 1988, Biochemistry.

[6]  K Fujikawa,et al.  The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.

[7]  J. Sheehan,et al.  Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Pritchard,et al.  Isolation and characterization of the tsetse thrombin inhibitor: a potent antithrombotic peptide from the saliva of Glossina morsitans morsitans. , 1996, The American journal of tropical medicine and hygiene.

[9]  P. Henderson,et al.  A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors. , 1972, The Biochemical journal.

[10]  W. Kane,et al.  Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. , 1988, Blood.

[11]  D. Monroe,et al.  A Cell-based Model of Hemostasis , 2001, Thrombosis and Haemostasis.

[12]  S. Coughlin,et al.  How the protease thrombin talks to cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  C. Esmon,et al.  The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V. , 1979, Biochimica et biophysica acta.

[14]  E. Di Cera,et al.  Molecular mechanisms of thrombin function , 1997, Cellular and Molecular Life Sciences CMLS.

[15]  R. Huber,et al.  The structure of a complex of recombinant hirudin and human alpha-thrombin. , 1990, Science.

[16]  J. Ribeiro,et al.  Anophelin: kinetics and mechanism of thrombin inhibition. , 1999, Biochemistry.

[17]  E. Cupp,et al.  Thrombostasin: purification, molecular cloning and expression of a novel anti-thrombin protein from horn fly saliva. , 2002, Insect biochemistry and molecular biology.

[18]  G. Broze,et al.  Factor XI activation in a revised model of blood coagulation , 1991, Science.

[19]  C. Esmon.  The regulation of natural anticoagulant pathways , 1987, Science.

[20]  V. Wheaton,et al.  Domains specifying thrombin–receptor interaction , 1991, Nature.

[21]  D. Tollefsen,et al.  Heparin cofactor II. Purification and properties of a heparin-dependent inhibitor of thrombin in human plasma. , 1982, The Journal of biological chemistry.

[22]  D. Turk,et al.  The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationships , 1992, Protein science : a publication of the Protein Society.

[23]  S. Coughlin,et al.  Thrombin signalling and protease-activated receptors , 2000, Nature.

[24]  C. Gibbs,et al.  Functional Mapping of the Surface Residues of Human Thrombin (*) , 1995, The Journal of Biological Chemistry.

[25]  J. Shafer,et al.  The COOH-terminal domain of hirudin. An exosite-directed competitive inhibitor of the action of alpha-thrombin on fibrinogen. , 1990, The Journal of biological chemistry.

[26]  R. Rosenberg,et al.  The purification and mechanism of action of human antithrombin-heparin cofactor. , 1973, The Journal of biological chemistry.

[27]  F. Markwardt,et al.  Reindarstellung und Analyse des Thrombininhibitors Hirudin , 1967 .

[28]  C. Esmon,et al.  Involvement of Thrombin Anion-binding Exosites 1 and 2 in the Activation of Factor V and Factor VIII* , 1996, The Journal of Biological Chemistry.

[29]  V. Wheaton,et al.  Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation , 1991, Cell.

[30]  J. Weitz,et al.  Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin. , 1998, The American journal of cardiology.

[31]  J. Ribeiro,et al.  Purification, cloning, and synthesis of a novel salivary anti-thrombin from the mosquito Anopheles albimanus. , 1999, Biochemistry.

[32]  F. Markwardt,et al.  [Purification and analysis of the thrombin inhibitor hirudin]. , 1967, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[33]  R. Huber,et al.  Refined structure of the hirudin-thrombin complex. , 1991, Journal of molecular biology.

[34]  W. Bode,et al.  A player of many parts: the spotlight falls on thrombin's structure. , 1993, Thrombosis research.

[35]  J. Sadler,et al.  Equilibrium binding of thrombin to recombinant human thrombomodulin: effect of hirudin, fibrinogen, factor Va, and peptide analogues. , 1990, Biochemistry.

[36]  C. Beard,et al.  Tsetse thrombin inhibitor: bloodmeal-induced expression of an anticoagulant in salivary glands and gut tissue of Glossina morsitans morsitans. , 1998, Proceedings of the National Academy of Sciences of the United States of America.